Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02990468 · MORE INFO

Limitations, agreements, and source contact

A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer · Source last updated 2023-03-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
This was a dose escalation study with all subjects receiving the intervention. There was no control arm for comparison. This will be addressed in a future clinical trial. This study design was effective for a safety, dose-escalation study.
point Of Contact
email
contact@bmxpharma.com
organization
BioMimetix JV LLC
phone
303-862-7268
title
Director of Clinical Operations
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
This was a dose escalation study with all subjects receiving the intervention. There was no control arm for comparison. This will be addressed in a future clinical trial. This study design was effective for a safety, dose-escalation study.
point Of Contact
email
contact@bmxpharma.com
organization
BioMimetix JV LLC
phone
303-862-7268
title
Director of Clinical Operations

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice